Cargando…

Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma

BACKGROUND: Systemic inflammation has been implicated in cancer development and progression. This study examined the best cutoff value of erythrocyte sedimentation rate (ESR) in diffuse large B-cell lymphoma (DLBCL) patients. METHODS: The relationship between ESR and clinical characteristics was ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Shuang, Zhou, Ye, Hua, Hai-Ying, Zhang, Yan, Zhu, Wen-Yan, Wang, Zhi-Qing, Li, Jin, Gao, Hua-Qiang, Wu, Xiao-Hong, Lu, Ting-Xun, Hua, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194702/ https://www.ncbi.nlm.nih.gov/pubmed/30340560 http://dx.doi.org/10.1186/s12885-018-4914-4

Ejemplares similares

Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma
por: Lu, Ting-Xun, et al.
Publicado: (2019)

Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma
por: Xiong, Fei, et al.
Publicado: (2021)

Novel HDAC inhibitor Chidamide synergizes with Rituximab to inhibit diffuse large B-cell lymphoma tumour growth by upregulating CD20
por: Guan, Xu-Wen, et al.
Publicado: (2020)

Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age
por: Lu, Ting-Xun, et al.
Publicado: (2015)

Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients
por: Zhong, Wei-Jie, et al.
Publicado: (2017)

Primary Gastric Diffuse Large B-Cell Lymphoma: Prognostic Factors in the Immuno-Oncology Therapeutics Era
por: Bai, ZhiMin, et al.
Publicado: (2020)

A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma
por: Liu, Yajiao, et al.
Publicado: (2023)

Primary sternum diffuse large B-cell lymphoma: A case report and a review of the literatur
por: Tong, Meng-Ying, et al.
Publicado: (2021)

The distinct clinical features and prognosis of the CD10(+)MUM1(+) and CD10(−)Bcl6(−)MUM1(−) diffuse large B-cell lymphoma
por: Lu, Ting-Xun, et al.
Publicado: (2016)

MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma
por: Lu, Ting-Xun, et al.
Publicado: (2015)

An Externally Validated Nomogram for Predicting the Overall Survival of Patients With Diffuse Large B-Cell Lymphoma Based on Clinical Characteristics and Systemic Inflammatory Markers
por: Liu, Yajiao, et al.
Publicado: (2023)

Combining PD-1 Inhibitor Nivolumab with Radiotherapy Successfully Treated a Patient with Refractory Primary Mediastinal Large B-Cell Lymphoma: A Case Report and Literature Review
por: Yan, Zheng, et al.
Publicado: (2020)

Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma
por: Li, Wen-Xing, et al.
Publicado: (2021)

Diffuse large B-cell lymphoma with pulmonary and cerebral involvement: A case report
por: Zeng, Jing, et al.
Publicado: (2018)

Use of subsequent PET/CT in diffuse large B-cell lymphoma patients in complete remission following primary therapy
por: Zhang, Xu, et al.
Publicado: (2015)

Gemcitabine, oxaliplatin and dexamethasone (GemDOx) as salvage therapy for relapsed or refractory diffuse large B-cell lymphoma and peripheral T-cell lymphoma
por: Shen, Qiu-Dan, et al.
Publicado: (2021)

Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma
por: Wang, Feng, et al.
Publicado: (2008)

Diabetes mellitus predicts inferior survival in diffuse large B-cell lymphoma: a propensity score-matched analysis
por: Gao, Rui, et al.
Publicado: (2019)

Primary diffuse large B-cell lymphoma of orbit: A population-based analysis
por: Chen, Yu-Qing, et al.
Publicado: (2022)

A model to predict the prognosis of diffuse large B-cell lymphoma based on ultrasound images
por: Lu, Wenjuan, et al.
Publicado: (2023)

Preliminary study of hypoxia markers in diffuse large B-cell lymphoma
por: Pangarsa, Eko A., et al.
Publicado: (2022)

Expression and Function of Toll-Like Receptor 10 (TLR10) in Diffuse Large B Cell Lymphoma, Acute Myeloid Leukemia, and Glioma
por: Ge, Le, et al.
Publicado: (2020)

Correlations between Functional Imaging Markers Derived from PET/CT and Diffusion-Weighted MRI in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
por: Wu, Xingchen, et al.
Publicado: (2014)

RAC1, a Potential Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma
por: Wu, Xue, et al.
Publicado: (2022)

Clinicopathological characteristics and treatment outcome in obese patients with diffuse large B-cell lymphoma
por: Wu, Yu-Ying, et al.
Publicado: (2020)

Leukemic Phase of CD5+ Diffuse Large B-Cell Lymphoma
por: Hsiao, Hui-Hua, et al.
Publicado: (2018)

Diffuse large B-cell lymphoma with continuously elevated immunoglobulin M following treatment: a case report with pathologic, immunophenotypic, and molecular analyses
por: Xiao, Fei, et al.
Publicado: (2023)

The beneficial effect of Escalated‐R‐CHOP‐21 for the treatment of diffuse large B‐cell lymphoma in elderly male patients: A propensity‐matched cohort study
por: He, Hai‐Xia, et al.
Publicado: (2021)

Diffuse Large B-Cell Lymphoma Arising within Ileal Neobladder: An Expanding Spectrum of Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation
por: Lee, Hyekyung, et al.
Publicado: (2019)

Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma
por: Zhu, Yue, et al.
Publicado: (2022)

Identification of three small nucleolar RNAs (snoRNAs) as potential prognostic markers in diffuse large B‐cell lymphoma
por: Li, Mei‐wei, et al.
Publicado: (2022)

The ESR Patient Advisory Group (ESR-PAG)
Publicado: (2015)

CircPVT1 promotes ER‐positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS
por: Yi, Jia, et al.
Publicado: (2023)

Expression of Tryptophan Metabolism Enzymes in Patients with Diffuse Large B‐cell Lymphoma and NK/T‐cell Lymphoma
por: Guo, Dan, et al.
Publicado: (2023)

Non-Coding RNAs in Diffuse Large B-Cell Lymphoma
por: Shi, Yan, et al.
Publicado: (2020)

Primary hepatic diffuse large B cell lymphoma: A case report: Primary hepatic diffuse large B cell lymphoma
por: Ma, Yuan-Ji, et al.
Publicado: (2011)

Epstein–Barr virus-positive diffuse large B-cell lymphoma features disrupted antigen capture/presentation and hijacked T-cell suppression
por: Jiang, Xiang-Nan, et al.
Publicado: (2019)

P1155: MORE PRECISE RISK STRATIFICATION FOR TP53 MUTANT DIFFUSE LARGE B CELL LYMPHOMA
por: Du, Kai-Xin, et al.
Publicado: (2023)

Qualitative visual trichotomous assessment improves the value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in predicting the prognosis of diffuse large B-cell lymphoma
por: Zhang, Xu, et al.
Publicado: (2015)

Clinical relevance of multi-drug resistance gene C3435T polymorphism in diffuse large B-cell lymphoma in Xinjiang
por: Liu, Wei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o651anq7r3hdmiugv8p1rc23bu